Skip to main content
. 2020 May 1;2020(5):CD008649. doi: 10.1002/14651858.CD008649.pub4

3.5. Analysis.

3.5

Comparison 3: Mannitol versus control ‐ parallel study of individuals with cystic fibrosis, hospitalised due to pulmonary exacerbations, Outcome 5: FEF25-75 % predicted (change from baseline)